Exforge hct and Multivitamin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Exforge hct (amlodipine; hydrochlorothiazide; valsartan) and Multivitamin (ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e). Common drug interactions include cerebrovascular accident among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Exforge hct and Multivitamin. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Exforge hct?

Exforge hct has active ingredients of amlodipine; hydrochlorothiazide; valsartan. It is often used in high blood pressure. eHealthMe is studying from 4,095 Exforge hct users. Check the latest studies of Exforge hct.

What is Multivitamin?

Multivitamin has active ingredients of ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e. It is often used in vitamin supplementation. eHealthMe is studying from 83,597 Multivitamin users. Check the latest studies of Multivitamin.



On Aug, 11, 2026

13 people who take Exforge hct and Multivitamin together, and have interactions are studied.

Exforge hct and Multivitamin drug interactions.

What are the common drug interactions of Exforge Hct and Multivitamin, by gender? *:

female:

  1. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  2. Ear discomfort
  3. Ear infection
  4. Eye pruritus (eye itching)
  5. Hypersensitivity
  6. Increased upper airway secretion
  7. Injection site erythema (redness at injection site)
  8. Injection site haematoma (localized swelling filled with blood at injection site)
  9. Injection site pruritus (severe itching at injection site)
  10. Joint crepitation

male:

  1. Asthenia (weakness)
  2. Deafness neurosensory
  3. Muscle atrophy (a decrease in the mass of the muscle)
  4. Muscular weakness (muscle weakness)
  5. Therapeutic response unexpected
  6. Visual impairment
  7. Abdominal discomfort
  8. Acute myocardial infarction (acute heart attack)
  9. Angina pectoris (chest pain due to ischemia of the heart muscle)
  10. Blood triglycerides increased

What are the common drug interactions of Exforge Hct and Multivitamin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Ear discomfort
  2. Ear infection
  3. Eye pruritus (eye itching)
  4. Hypersensitivity
  5. Increased upper airway secretion
  6. Injection site erythema (redness at injection site)
  7. Injection site haematoma (localized swelling filled with blood at injection site)
  8. Injection site pruritus (severe itching at injection site)
  9. Joint crepitation
  10. Lacrimation increased

60+:

  1. Asthenia (weakness)
  2. Deafness neurosensory
  3. Muscle atrophy (a decrease in the mass of the muscle)
  4. Muscular weakness (muscle weakness)
  5. Pruritus (severe itching of the skin)
  6. Therapeutic response unexpected
  7. Visual impairment
  8. Abdominal discomfort
  9. Diarrhoea
  10. Dizziness

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 23.08%
  2. Pain: 3 people, 23.08%
  3. Stress And Anxiety: 2 people, 15.38%
  4. Sleep Disorder: 2 people, 15.38%
  5. Enlarged Prostate: 2 people, 15.38%
  6. Gait Disturbance: 2 people, 15.38%
  7. High Blood Cholesterol: 2 people, 15.38%
  8. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 15.38%
  9. Depression: 2 people, 15.38%
  10. Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 2 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Exforge hct and Multivitamin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Exforge hct and Multivitamin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Exforge hct:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Multivitamin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Exforge hct and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Multivitamin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on amlodipine; hydrochlorothiazide; valsartan and ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e (the active ingredients of Exforge hct and Multivitamin, respectively), and Exforge hct and Multivitamin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: